PRYGOCKI MARK A SR
Insider CIK 1257544 · RVNC Director · VRCA Director · CRXT Director · MRX President
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2026-06-05 | 2026-06-09 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2025-06-05 | 2025-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2024-06-06 | 2024-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2023-06-08 | 2023-06-12 | 10,384 | — | $0 | 10,384 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2022-06-09 | 2022-06-13 | 10,384 | — | $0 | 10,384 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | A Award deriv | 2022-06-07 | 2022-06-09 | 4,805 | — | $0 | 4,805 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | A Award | 2022-06-07 | 2022-06-09 | 1,922 | — | $0 | 5,766 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | A Award deriv | 2021-12-12 | 2021-12-14 | 9,610 | — | $0 | 9,610 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | A Award | 2021-12-12 | 2021-12-14 | 3,844 | — | $0 | 3,844 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2021-06-10 | 2021-06-14 | 5,834 | — | $0 | 5,834 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2021-06-10 | 2021-06-17 | 8,109 | — | $0 | 8,109 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2020-06-11 | 2020-06-12 | 5,834 | — | $0 | 5,834 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2019-06-12 | 2019-06-14 | 5,834 | — | $0 | 5,834 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2018-06-14 | 2018-06-18 | 17,502 | — | $0 | 17,502 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2016-05-05 | 2016-05-09 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-05-07 | 2015-05-14 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2014-05-12 | 2014-05-14 | 18,000 | — | $0 | 18,000 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 33,232 | $11.59 | $385.2K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 3,424 | $14.80 | $50.7K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 84,000 | $5.55 | $466.2K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 4,768 | $11.59 | $55.3K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 76,733 | $14.80 | $1.14M | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer | 2012-12-11 | 2012-12-13 | 301,613 | $44.00 | $13.27M | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer | 2012-12-11 | 2012-12-13 | 552 | $44.00 | $24.3K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | G Gift | 2012-12-07 | 2012-12-13 | 2,300 | — | $0 | 301,613 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | F Tax w/h | 2012-04-04 | 2012-04-05 | 5,293 | $38.23 | $202.4K | 303,913 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | F Tax w/h | 2012-03-07 | 2012-03-09 | 3,178 | $34.71 | $110.3K | 309,206 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | F Tax w/h | 2012-03-01 | 2012-03-05 | 2,747 | $34.95 | $96.0K | 313,968 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | F Tax w/h | 2012-03-01 | 2012-03-05 | 1,584 | $34.95 | $55.4K | 312,384 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | A Award | 2012-02-29 | 2012-03-02 | 42,930 | — | $0 | 316,715 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | F Tax w/h | 2012-02-27 | 2012-02-29 | 7,832 | $33.81 | $264.8K | 273,785 | SEC↗ |